XRCC1 and breast carcinoma: Our analysis demonstrated significantly higher protein expression levels of XRCC1 in primary tissues of GBM, hepatocellular carcinoma, head and neck squamous carcinoma, breast cancer, colon cancer, lung adenocarcinoma (LUAD), and ovarian cancer compared to normal tissues (Figure 1C).